Skip to content

Evaluation of herbal formulation in contact dermatitis

Clinical evaluation of herbal formulation in Mild to Moderate Contact Dermatitis - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055420
Enrollment
60
Registered
2023-07-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L259- Unspecified contact dermatitis, unspecified cause

Interventions

None listed

Sponsors

Plant Ayu Life Sciences LLP Pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age from 18 - 60 yrs 2. Mild to moderate SCORing Atopic Dermatitis (SCORAD) > 5 % for > 1 months 3. Body surface involvement (BSI) of > 5% 4. Male or female 5. Willing to provide voluntary written informed consent.

Exclusion criteria

Exclusion criteria: 1) Pregnant women and lactating mothers. 2) Patients suffering from systemic disorders as Cardiac, renal and hepatic diseases, Uncontrolled Diabetes mellitus, Uncontrolled Hypertension, Paralysis, Malignancy, Human immune deficiency virus infection, HBsAg, Leprosy. 3) Patients suffering from Psoriatic arthritis. 4) Patients who have received systemic therapy for psoriasis or those who have been treated with immunosuppressive immune - modulating treatment in previous 8 weeks. 5) Patient with personal or family history of malignant or premalignant skin tumours. 6) Subject with active infection either acute or chronic by fungi, viruses bacteria and parasites

Design outcomes

Primary

MeasureTime frame
The primary outcome of the study is to evaluate the changes in SCORing Atopic Dermatitis (SCORAD)Timepoint: baseline to 60 days

Secondary

MeasureTime frame
The Secondary outcome of the study is to evaluate the changes in Dermatology Life Quality Index(DLQI)Timepoint: baseline to 60 days

Countries

India

Contacts

Public ContactDr Sarvesh Kumar Singh

National Institute of Ayurveda

sarveshksingh21@gmail.com8739860237

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026